Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade

This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune‐related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Jarushka, Cappelli, Laura C., Forde, Patrick M., Marrone, Kristen A., Lipson, Evan J., Hammers, Hans J., Sharfman, William H., Le, Dung T., Baer, Alan N., Shah, Ami A., Albayda, Jemima, Manno, Rebecca L., Haque, Uzma, Gutierrez, Anna Kristina, Bingham, Clifton O., Brahmer, Julie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469592/
https://www.ncbi.nlm.nih.gov/pubmed/28576858
http://dx.doi.org/10.1634/theoncologist.2016-0390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469592/
https://www.ncbi.nlm.nih.gov/pubmed/28576858
http://dx.doi.org/10.1634/theoncologist.2016-0390

Ejemplares similares